1. Home
  2. RCKT vs RXT Comparison

RCKT vs RXT Comparison

Compare RCKT & RXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • RXT
  • Stock Information
  • Founded
  • RCKT 1999
  • RXT 1998
  • Country
  • RCKT United States
  • RXT United States
  • Employees
  • RCKT N/A
  • RXT N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • RXT EDP Services
  • Sector
  • RCKT Health Care
  • RXT Technology
  • Exchange
  • RCKT Nasdaq
  • RXT Nasdaq
  • Market Cap
  • RCKT 328.6M
  • RXT 332.7M
  • IPO Year
  • RCKT N/A
  • RXT 2020
  • Fundamental
  • Price
  • RCKT $3.17
  • RXT $1.43
  • Analyst Decision
  • RCKT Buy
  • RXT Hold
  • Analyst Count
  • RCKT 13
  • RXT 5
  • Target Price
  • RCKT $12.88
  • RXT $1.58
  • AVG Volume (30 Days)
  • RCKT 2.3M
  • RXT 1.1M
  • Earning Date
  • RCKT 11-06-2025
  • RXT 11-11-2025
  • Dividend Yield
  • RCKT N/A
  • RXT N/A
  • EPS Growth
  • RCKT N/A
  • RXT N/A
  • EPS
  • RCKT N/A
  • RXT N/A
  • Revenue
  • RCKT N/A
  • RXT $2,693,100,000.00
  • Revenue This Year
  • RCKT N/A
  • RXT N/A
  • Revenue Next Year
  • RCKT $108.43
  • RXT $1.59
  • P/E Ratio
  • RCKT N/A
  • RXT N/A
  • Revenue Growth
  • RCKT N/A
  • RXT N/A
  • 52 Week Low
  • RCKT $2.19
  • RXT $1.00
  • 52 Week High
  • RCKT $18.89
  • RXT $3.41
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 48.26
  • RXT 52.95
  • Support Level
  • RCKT $3.13
  • RXT $1.34
  • Resistance Level
  • RCKT $3.44
  • RXT $1.58
  • Average True Range (ATR)
  • RCKT 0.17
  • RXT 0.08
  • MACD
  • RCKT -0.01
  • RXT -0.00
  • Stochastic Oscillator
  • RCKT 35.11
  • RXT 35.42

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About RXT Rackspace Technology Inc.

Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.

Share on Social Networks: